Aurora Cannabis Reveals Latest Product Innovations: Ultra-High Potency Indicas And Strains For Veterans
Express News | DEA Says Formal Hearing Proceedings Regarding Proposed Rescheduling Of Marijuana Will Begin On Dec 2 At 9:30 A.m. ET
Express News | 'Federal Health Officials 'Rejected' DEA's Request To Testify At Marijuana Rescheduling Hearing, Agency Tells Judge' - Marijuana Moment
Express News | 'Democratic Congressional Lawmakers Push Biden To Issue Marijuana Executive Order Before Trump Takes Office' - Marijuana Moment
Express News | Watching Aurora Cannabis; Traders Circulate Zacks Newsletter Picks Stock
Aurora Cannabis Brief: Announcing Medical Product Advancements From Leading Cannabis Research Facility
Aurora Announces Medical Product Advancements From Leading Cannabis Research Facility
Tom Angell Says "DEA Says It Is in the Process of Preparing Public Access to the Cannabis Rescheduling Proceedings Docket. For Now, Read Marijuana Moment's Coverage of the Latest Significant Filings:", 'DEA And Anti-Marijuana Group Deny Allegations...
German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
Canopy Growth, Aurora And Another Cannabis Giant Unveil Product Innovations, Here's What's New
Express News | Aurora Cannabis Announced Its Latest Lineup Of Innovations From Greybeard, San Rafael '71 And Tasty's Brands
Aurora Cannabis Brief: Expanding Recreational Product Portfolio; Introduces New Products and Flavours Across Greybeard, San Rafael '71 and Tasty's Brands
Aurora Cannabis Expands Innovative Recreational Product Portfolio
US Manufacturing Index Rises To 43, Highest Since 2020
Aurora Cannabis Set for Seven Straight Sessions of Losses
Gaetz as Trump's AG Seen as Bullish for Pot Stocks, but Confirmation Looks Unlikely
Express News | Shares of Cannabis-linked Stocks Are Trading Higher After Chris Christie in a Benzinga Exclusive Suggested He Thinks Trump May Attempt to Change Marijuana to a Non-scheduled Drug That Wouldn't Be Illegal
Aurora Cannabis Second Quarter 2025 Earnings: EPS: CA$0.05 (Vs CA$0.048 in 2Q 2024)
Correction to Aurora Cannabis 2Q Net Headline on Nov. 6
No Data